DOCSLIB.ORG

Treating Small Fiber Neuropathy by Topical Application of a Small

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Treating Small Fiber Neuropathy by Topical Application of a Small Treating small fiber neuropathy by topical application SEE COMMENTARY of a small molecule modulator of ligand-induced GFRα/RET receptor signaling Kristian L. Hedstroma,b,1, Joshua C. Murtiea,b,1, Kathryn Albersc, Nigel A. Calcuttd, and Gabriel Corfasa,b,e,2 aF. M. Kirby Neurobiology Center, Children’s Hospital Boston, Harvard Medical School, Boston, MA 02115; Departments of bNeurology and eOtology and Laryngology, Harvard Medical School, Boston, MA 02115; cDepartment of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15260; and dDepartment of Pathology, University of California, San Diego, La Jolla, CA 92093-0612 Edited* by Joseph Schlessinger, Yale University School of Medicine, New Haven, CT, and approved December 20, 2013 (received for review May 10, 2013) Small-fiber neuropathy (SFN) is a disorder of peripheral nerves two mouse models of progressive SFN. We found that GDNF commonly found in patients with diabetes mellitus, HIV infection, and skin overexpression and topical XIB4035 are equally effective in those receiving chemotherapy. The complexity of disease etiology treating SFN caused by dysfunction of nonmyelinating Schwann cells has led to a scarcity of effective treatments. Using two models of and that topical XIB4035 treatment also ameliorates SFN symptoms progressive SFN, we show that overexpression of glial cell line-derived in a mouse model of diabetic SFN. Furthermore, we establish that neurotrophic factor (GDNF) in skin keratinocytes or topical application XIB4035 is not a GDNF mimetic as previously reported, but rather of XIB4035, a reported nonpeptidyl agonist of GDNF receptor α1 a positive modulator that enhances ligand-induced GFL receptor (GFRα1), are effective treatments for SFN. We also demonstrate that function. Together, our results suggest that modulation of GFL XIB4035 is not a GFRα1 agonist, but rather it enhances GFRα family signaling is an effective, disease-modifying treatment for SFN, receptor signaling in conjunction with ligand stimulation. Taken and we identify XIB4035 as a potentially therapeutic molecule. together, our results indicate that topical application of GFRα/RET receptor signaling modulators may be a unique therapy for SFN, and Results we have identified XIB4035 as a candidate therapeutic agent. Overexpression of GDNF by Keratinocytes Prevents Progressive SFN. NEUROSCIENCE We previously characterized a transgenic mouse line (line D) ex- topical drug | pain | thermonociception | sensory | trophic factor pressing a dominant-negative ErbB4 receptor in nonmyelinating Schwann cells (NMSCs) (7). The truncated ErbB4 receptor forms mall-fiber neuropathy (SFN), i.e., damage or dysfunction of nonfunctional dimers with wild-type ErbB2 and ErbB3 expressed Ssmall-diameter axons (C fibers) in peripheral nerves, is a by these glia, rendering them nonfunctional (7, 21). By the age prevalent neurological disorder that afflicts an estimated 1.5% of of 21 d [postnatal day 21 (P21)] line-D mice present mild SFN the world’s population and millions of people in the United symptoms, which worsen rapidly (7). The SFN in this model in- States (1–3). SFN is associated with diabetes, HIV infection, and volves loss of thermal nociception, breakdown of Remak bundles chemotherapy treatment, but many patients suffer from idio- (unmyelinated axons surrounded by a NMSC), and degeneration pathic SFN (3–5). SFN patients can exhibit a large variety of of C-fiber axons (7). Furthermore, analysis of the glabrous skin of symptoms, including loss of sensation and chronic pain. Despite the footpad using the panneuronal marker protein gene product the pervasiveness of SFN, its etiology is poorly understood, 9.5 (PGP9.5) showed these mice also have progressive loss of resulting in a lack of disease-modifying treatments. intraepidermal nerve fiber (IENF) density (Fig. S1), a parameter Initial stages of SFN commonly involve nerve terminal de- considered a clinical indicator of neuropathy severity in humans generation before sensory neuron death (6), and reduction in target- derived trophic factor expression has been observed in multiple Significance models of peripheral neuropathy (7, 8). Therefore, replenishing or replacing neurotrophic factors promptly after disease onset could potentially be used as a treatment to promote the survival and re- Small-fiber neuropathy (SFN) is a disorder of peripheral nerves that store the function of C-fiber neurons (9, 10). One group of trophic affects millions of people around the world. Currently, there are no factors necessary for development and survival of C fibers is the glial treatments for SFN, but target-derived neurotrophic factors have been considered potential therapeutics. Here, we show that top- cell line-derived neurotrophic factor (GDNF) family ligands (GFLs) ical application of XIB4035, a small molecule that enhances sig- (10, 11). Each family member interacts selectively with a different naling by the glial-derived neurotrophic factor family of high affinity receptor: GDNF with GDNF receptor α1(GFRα1), molecules, ameliorates SFN pathologies and symptoms in neurturin (NRTN) with GFRα2, artemin (ARTN) with GFRα3, and two mouse models. These findings imply that XIB4035 or re- persephin (PSPN) with GFRα4, although GDNF and NRTN have lated molecules could provide a new strategy for SFN treatment the capacity to bind and activate GFRα2andGFRα1, respectively with potentially lower risk for side effects because of the topical (12). Each ligand/receptor pair forms a complex with the RET re- delivery route and their limited signaling effects. ceptor tyrosine kinase, resulting in downstream effects that include tyrosine hydroxylase (TH) gene transcription (13, 14). GFLs not only Author contributions: K.L.H., J.C.M., K.A., N.A.C., and G.C. designed research; K.L.H., J.C.M., play a pivotal role in sensory neuron development, but also appear to and N.A.C. performed research; K.L.H., J.C.M., and G.C. analyzed data; and K.L.H., J.C.M., and be beneficial in the context of peripheral nerve injury. For example, G.C. wrote the paper. systemic, transgenic, or viral delivery of GFLs has been shown to Conflict of interest statement: G.C. and J.C.M. are inventors on patent US7863295B2 attenuate neuropathic symptoms in mouse models of nerve injury associated with this work and owned by Children’s Medical Center Corporation. (15–19). Thus, we hypothesized that topical delivery of GDNF re- *This Direct Submission article had a prearranged editor. ceptor agonists to the skin would be an effective, noninvasive ther- See Commentary on page 2060. apeutic approach for treating progressive SFN. 1These authors contributed equally to this work. In the present study, we tested whether GDNF skin overex- 2To whom correspondence should be addressed. E-mail: [email protected]. pression or topical application of XIB4035, a reported nonpeptidyl This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. small-molecule agonist for GFRα1(20),couldbeusedtotreat 1073/pnas.1308889111/-/DCSupplemental. www.pnas.org/cgi/doi/10.1073/pnas.1308889111 PNAS | February 11, 2014 | vol. 111 | no. 6 | 2325–2330 Downloaded by guest on September 25, 2021 (22) and in animal models of SFN (23). Interestingly, line-D SFN correlates with a significant reduction of GDNF protein in pe- ripheral nerves (7). We hypothesized that the reduced levels of GDNF contributes to the pathogenesis of the SFN, and that in- creasing the availability of target (i.e., skin)-derived GDNF could modify the SFN in line-D mice. To test this hypothesis, we crossed line-D mice with a transgenic line that overexpresses GDNF in the skin under the control of the keratin 14 promoter (K14-GDNF) (11). Importantly, K14-GDNF mice have normal thermonoci- ception despite having increased IENF density (11). Behavioral analysis demonstrated that, as shown previously (7), line-D mice exhibit a dramatic loss in thermal nociception at 6 wk of age (Fig. 1A). In contrast, thermonociception in double-transgenic mice (line-D::K14-GDNF) is indistinguishable from that in wild-type and K14-GDNF mice (Fig. 1A). Microscopy showed that line-D:: K14-GDNF mice have normal sciatic nerve Remak bundles (Fig. S2A) and retain intraepidermal innervation (Fig. S2 B and C). IENF density in double-transgenic mice is lower than in K14- GDNF mice, but the magnitude of the reduction (40%) is much lower than in line-D mice compared with wild type (81%). Topical Application of XIB4035 Curtails Progression of SFN in Two Animal Models. Transgenic GDNF overexpression served as a proof-of-concept that increasing skin GDNF levels could prevent progressive SFN in line-D mice. However, K14-GDNF mice overexpress GDNF during embryogenesis, altering sensory neuron development, which could contribute to the apparent therapeutic Fig. 1. Overexpression of GDNF in the skin or topically applied XIB4035 curtails effects. Also, when considering clinical use, GDNF overexpression progression of SFN in two animal models. (A) Hot-plate (54 °C) test shows that the in the skin would require gene therapy, with its drawbacks and loss of thermal nociception in line-D mice is prevented by GDNF overexpression in complications, and dermal GDNF application would not work, as keratinocytes (K14-GDNF). Only responses of line-D differ from those observed in peptides do not readily penetrate the skin. Therefore, we tested the other three genotypes (one-way ANOVA with Newman–Keuls post hoc test, whether topical application of XIB4035, a nonpeptidyl small n ≥ 3; ***P < 0.001; error bars indicate SEM). (B) Hot-plate (54 °C) test shows that molecule reported to be an agonist for GFRα1 (20), could mimic XIB4035 treatment starting at P21 prevents loss of thermal nociception in line-D the effects of GDNF overexpression in the skin. We applied a mice. Wild-type (WT) and line-D mice were randomly divided into two groups at cream containing XIB4035 (1.5 mM) to the hindpaws of line-D P21, a stage at which line-D mice had a small but significant increase in paw = and wild-type mice starting at weaning (P21), when mutant mice withdrawal latency compared with WT animals (Student t test, P 0.0002).
Load more

Recommended publications
  • Signalling Between Microvascular Endothelium and Cardiomyocytes Through Neuregulin Downloaded From
    Cardiovascular Research (2014) 102, 194–204 SPOTLIGHT REVIEW doi:10.1093/cvr/cvu021 Signalling between microvascular endothelium and cardiomyocytes through neuregulin Downloaded from Emily M. Parodi and Bernhard Kuhn* Harvard Medical School, Boston Children’s Hospital, 300 Longwood Avenue, Enders Building, Room 1212, Brookline, MA 02115, USA Received 21 October 2013; revised 23 December 2013; accepted 10 January 2014; online publish-ahead-of-print 29 January 2014 http://cardiovascres.oxfordjournals.org/ Heterocellular communication in the heart is an important mechanism for matching circulatory demands with cardiac structure and function, and neuregulins (Nrgs) play an important role in transducing this signal between the hearts’ vasculature and musculature. Here, we review the current knowledge regarding Nrgs, explaining their roles in transducing signals between the heart’s microvasculature and cardiomyocytes. We highlight intriguing areas being investigated for developing new, Nrg-mediated strategies to heal the heart in acquired and congenital heart diseases, and note avenues for future research. ----------------------------------------------------------------------------------------------------------------------------------------------------------- Keywords Neuregulin Heart Heterocellular communication ErbB -----------------------------------------------------------------------------------------------------------------------------------------------------------† † † This article is part of the Spotlight Issue on: Heterocellular signalling
    [Show full text]
  • RET Controls Sympathetic Innervation
    Development 128, 3963-3974 (2001) 3963 Printed in Great Britain © The Company of Biologists Limited 2001 DEV8811 RET signaling is essential for migration, axonal growth and axon guidance of developing sympathetic neurons Hideki Enomoto1, Peter A. Crawford1, Alexander Gorodinsky1, Robert O. Heuckeroth2,3, Eugene M. Johnson, Jr3 and Jeffrey Milbrandt1,* 1Departments of Pathology and Internal Medicine, Washington University School of Medicine, 660 South Euclid Avenue, Box 8118, St Louis, MO 63110, USA 2Department of Pediatrics, Washington University School of Medicine, 660 South Euclid Avenue, Box 8116, St Louis, MO 63110, USA 3Department of Molecular Biology and Pharmacology, Washington University School of Medicine, 660 South Euclid Avenue, Box 8113, St Louis, MO 63110, USA *Author for correspondence (e-mail: [email protected]) Accepted 26 July 2001 SUMMARY Sympathetic axons use blood vessels as an intermediate trunks and accelerated cell death of sympathetic neurons path to reach their final target tissues. The initial contact later in development. Artemin is expressed in blood vessels between differentiating sympathetic neurons and blood during periods of early sympathetic differentiation, and vessels occurs following the primary sympathetic chain can promote and attract axonal growth of the sympathetic formation, where precursors of sympathetic neurons ganglion in vitro. This analysis identifies RET and artemin migrate and project axons along or toward blood vessels. as central regulators of early sympathetic innervation. We demonstrate
    [Show full text]
  • Molecular Mediators of Acute and Chronic Itch in Mouse and Human Sensory Neurons Manouela Valtcheva Washington University in St
    Washington University in St. Louis Washington University Open Scholarship Arts & Sciences Electronic Theses and Dissertations Arts & Sciences Spring 5-15-2018 Molecular Mediators of Acute and Chronic Itch in Mouse and Human Sensory Neurons Manouela Valtcheva Washington University in St. Louis Follow this and additional works at: https://openscholarship.wustl.edu/art_sci_etds Part of the Neuroscience and Neurobiology Commons Recommended Citation Valtcheva, Manouela, "Molecular Mediators of Acute and Chronic Itch in Mouse and Human Sensory Neurons" (2018). Arts & Sciences Electronic Theses and Dissertations. 1596. https://openscholarship.wustl.edu/art_sci_etds/1596 This Dissertation is brought to you for free and open access by the Arts & Sciences at Washington University Open Scholarship. It has been accepted for inclusion in Arts & Sciences Electronic Theses and Dissertations by an authorized administrator of Washington University Open Scholarship. For more information, please contact [email protected]. WASHINGTON UNIVERSITY IN ST. LOUIS Division of Biology and Biomedical Sciences Neurosciences Dissertation Examination Committee: Robert W. Gereau, IV, Chair Yu-Qing Cao Sanjay Jain Qin Liu Durga Mohapatra Molecular Mediators of Acute and Chronic Itch in Mouse and Human Sensory Neurons by Manouela Vesselinova Valtcheva A dissertation presented to The Graduate School of Washington University in partial fulfillment of the requirements for the degree of Doctor of Philosophy May 2018 St. Louis, Missouri © 2018, Manouela V. Valtcheva Table
    [Show full text]
  • Angiocrine Endothelium: from Physiology to Cancer Jennifer Pasquier1,2*, Pegah Ghiabi2, Lotf Chouchane3,4,5, Kais Razzouk1, Shahin Rafi3 and Arash Rafi1,2,3
    Pasquier et al. J Transl Med (2020) 18:52 https://doi.org/10.1186/s12967-020-02244-9 Journal of Translational Medicine REVIEW Open Access Angiocrine endothelium: from physiology to cancer Jennifer Pasquier1,2*, Pegah Ghiabi2, Lotf Chouchane3,4,5, Kais Razzouk1, Shahin Rafi3 and Arash Rafi1,2,3 Abstract The concept of cancer as a cell-autonomous disease has been challenged by the wealth of knowledge gathered in the past decades on the importance of tumor microenvironment (TM) in cancer progression and metastasis. The sig- nifcance of endothelial cells (ECs) in this scenario was initially attributed to their role in vasculogenesis and angiogen- esis that is critical for tumor initiation and growth. Nevertheless, the identifcation of endothelial-derived angiocrine factors illustrated an alternative non-angiogenic function of ECs contributing to both physiological and pathological tissue development. Gene expression profling studies have demonstrated distinctive expression patterns in tumor- associated endothelial cells that imply a bilateral crosstalk between tumor and its endothelium. Recently, some of the molecular determinants of this reciprocal interaction have been identifed which are considered as potential targets for developing novel anti-angiocrine therapeutic strategies. Keywords: Angiocrine, Endothelium, Cancer, Cancer microenvironment, Angiogenesis Introduction of blood vessels in initiation of tumor growth and stated Metastatic disease accounts for about 90% of patient that in the absence of such angiogenesis, tumors can- mortality. Te difculty in controlling and eradicating not expand their mass or display a metastatic phenotype metastasis might be related to the heterotypic interaction [7]. Based on this theory, many investigators assumed of tumor and its microenvironment [1].
    [Show full text]
  • Artemin, a Novel Member of the GDNF Ligand Family, Supports Peripheral and Central Neurons and Signals Through the GFR␣3–RET Receptor Complex
    CORE Metadata, citation and similar papers at core.ac.uk Provided by Elsevier - Publisher Connector Neuron, Vol. 21, 1291±1302, December, 1998, Copyright 1998 by Cell Press Artemin, a Novel Member of the GDNF Ligand Family, Supports Peripheral and Central Neurons and Signals through the GFRa3±RET Receptor Complex Robert H. Baloh,* Malu G. Tansey,² et al., 1998; Milbrandt et al., 1998; reviewed by Grondin Patricia A. Lampe,² Timothy J. Fahrner,* and Gash, 1998). However, the GDNF ligands also influ- Hideki Enomoto,* Kelli S. Simburger,* ence a broad spectrum of other neuronal populations Melanie L. Leitner,² Toshiyuki Araki,* in both the CNS and PNS. GDNF and NTN both support Eugene M. Johnson, Jr.,² the survival of many peripheral neurons in culture, in- and Jeffrey Milbrandt*³ cluding sympathetic, parasympathetic, sensory, and en- *Department of Pathology and teric neurons (Buj-Bello et al., 1995; Ebendal et al., 1995; Department of Internal Medicine Trupp et al., 1995; Kotzbauer et al., 1996; Heuckeroth ² Department of Neurology and et al., 1998). In contrast, PSP does not share any of Department of Molecular Biology these peripheral activities but does support the survival and Pharmacology of dopaminergic midbrain neurons and motor neurons Washington University (Milbrandt et al., 1998). Despite the fact that GDNF acts School of Medicine on many cell populations in vitro, analysis of GDNF St. Louis, Missouri 63110 knockout mice revealed that the major developmental importance of GDNF is in the enteric nervous system and in kidney organogenesis, both of which are lost in Summary GDNF null mice (Moore et al., 1996; Pichel et al., 1996; Sanchez et al., 1996).
    [Show full text]
  • Intravitreal Co-Administration of GDNF and CNTF Confers Synergistic and Long-Lasting Protection Against Injury-Induced Cell Death of Retinal † Ganglion Cells in Mice
    cells Article Intravitreal Co-Administration of GDNF and CNTF Confers Synergistic and Long-Lasting Protection against Injury-Induced Cell Death of Retinal y Ganglion Cells in Mice 1, 1, 1 2 2 Simon Dulz z , Mahmoud Bassal z, Kai Flachsbarth , Kristoffer Riecken , Boris Fehse , Stefanie Schlichting 1, Susanne Bartsch 1 and Udo Bartsch 1,* 1 Department of Ophthalmology, Experimental Ophthalmology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany; [email protected] (S.D.); [email protected] (M.B.); kaifl[email protected] (K.F.); [email protected] (S.S.); [email protected] (S.B.) 2 Research Department Cell and Gene Therapy, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany; [email protected] (K.R.); [email protected] (B.F.) * Correspondence: [email protected]; Tel.: +49-40-7410-55945 A first draft of this manuscript is part of the unpublished doctoral thesis of Mahmoud Bassal. y Shared first authorship. z Received: 9 August 2020; Accepted: 9 September 2020; Published: 11 September 2020 Abstract: We have recently demonstrated that neural stem cell-based intravitreal co-administration of glial cell line-derived neurotrophic factor (GDNF) and ciliary neurotrophic factor (CNTF) confers profound protection to injured retinal ganglion cells (RGCs) in a mouse optic nerve crush model, resulting in the survival of ~38% RGCs two months after the nerve lesion. Here, we analyzed whether this neuroprotective effect is long-lasting and studied the impact of the pronounced RGC rescue on axonal regeneration. To this aim, we co-injected a GDNF- and a CNTF-overexpressing neural stem cell line into the vitreous cavity of adult mice one day after an optic nerve crush and determined the number of surviving RGCs 4, 6 and 8 months after the lesion.
    [Show full text]
  • Effects of PACAP on Schwann Cells
    International Journal of Molecular Sciences Review Effects of PACAP on Schwann Cells: Focus on Nerve Injury 1, 2, 1 3 Grazia Maugeri y, Agata Grazia D’Amico y, Giuseppe Musumeci , Dora Reglodi and Velia D’Agata 1,* 1 Department of Biomedical and Biotechnological Sciences, Section of Anatomy, Histology and Movement Sciences, University of Catania, 95100 Catania, Italy; [email protected] (G.M.); [email protected] (G.M.) 2 Department of Drug Sciences, University of Catania, 95100 Catania, Italy; [email protected] 3 Department of Anatomy, MTA-PTE PACAP Research Team, University of Pécs Medical School, Szigeti út 12, H-7624 Pécs, Hungary; [email protected] * Correspondence: [email protected]; Tel.: +39-095-3782039 These authors contributed equally to this work. y Received: 29 September 2020; Accepted: 2 November 2020; Published: 3 November 2020 Abstract: Schwann cells, the most abundant glial cells of the peripheral nervous system, represent the key players able to supply extracellular microenvironment for axonal regrowth and restoration of myelin sheaths on regenerating axons. Following nerve injury, Schwann cells respond adaptively to damage by acquiring a new phenotype. In particular, some of them localize in the distal stump to form the Bungner band, a regeneration track in the distal site of the injured nerve, whereas others produce cytokines involved in recruitment of macrophages infiltrating into the nerve damaged area for axonal and myelin debris clearance. Several neurotrophic factors, including pituitary adenylyl cyclase-activating peptide (PACAP), promote survival and axonal elongation of injured neurons. The present review summarizes the evidence existing in the literature demonstrating the autocrine and/or paracrine action exerted by PACAP to promote remyelination and ameliorate the peripheral nerve inflammatory response following nerve injury.
    [Show full text]
  • Neurotrophins and Their Receptors: a Convergence Point for Many Signalling Pathways
    REVIEWS NEUROTROPHINS AND THEIR RECEPTORS: A CONVERGENCE POINT FOR MANY SIGNALLING PATHWAYS Moses V.Chao The neurotrophins are a family of proteins that are essential for the development of the vertebrate nervous system. Each neurotrophin can signal through two different types of cell surface receptor — the Trk receptor tyrosine kinases and the p75 neurotrophin receptor. Given the wide range of activities that are now associated with neurotrophins, it is probable that additional regulatory events and signalling systems are involved. Here, I review recent findings that neurotrophins, in addition to promoting survival and differentiation, exert various effects through surprising interactions with other receptors and ion channels. 5,6 LONG-TERM POTENTIATION The era of growth factor research began fifty years ago receptor . Despite considerable progress in understand- (LTP).An enduring increase in with the discovery of nerve growth factor (NGF). Since ing the roles of these receptors, additional mechanisms the amplitude of excitatory then, the momentum to study the NGF — or neu- are needed to explain the many cellular and synaptic postsynaptic potentials as a rotrophin — family has never abated because of their interactions that occur between neurons. An emerging result of high-frequency (tetanic) stimulation of afferent continuous capacity to provide new insights into neural view is that neurotrophin receptors act as sensors for var- pathways. It is measured both as function; the influence of neurotrophins spans from ious extracellular and intracellular inputs, and several the amplitude of excitatory developmental neurobiology to neurodegenerative and new mechanisms have recently been put forward. Here, I postsynaptic potentials and as psychiatric disorders. In addition to their classic effects will consider several ways in which Trk and p75 receptors the magnitude of the postsynaptic-cell population on neuronal cell survival, neurotrophins can also regu- might account for the unique effects of neurotrophins spike.
    [Show full text]
  • Development and Validation of a Protein-Based Risk Score for Cardiovascular Outcomes Among Patients with Stable Coronary Heart Disease
    Supplementary Online Content Ganz P, Heidecker B, Hveem K, et al. Development and validation of a protein-based risk score for cardiovascular outcomes among patients with stable coronary heart disease. JAMA. doi: 10.1001/jama.2016.5951 eTable 1. List of 1130 Proteins Measured by Somalogic’s Modified Aptamer-Based Proteomic Assay eTable 2. Coefficients for Weibull Recalibration Model Applied to 9-Protein Model eFigure 1. Median Protein Levels in Derivation and Validation Cohort eTable 3. Coefficients for the Recalibration Model Applied to Refit Framingham eFigure 2. Calibration Plots for the Refit Framingham Model eTable 4. List of 200 Proteins Associated With the Risk of MI, Stroke, Heart Failure, and Death eFigure 3. Hazard Ratios of Lasso Selected Proteins for Primary End Point of MI, Stroke, Heart Failure, and Death eFigure 4. 9-Protein Prognostic Model Hazard Ratios Adjusted for Framingham Variables eFigure 5. 9-Protein Risk Scores by Event Type This supplementary material has been provided by the authors to give readers additional information about their work. Downloaded From: https://jamanetwork.com/ on 10/02/2021 Supplemental Material Table of Contents 1 Study Design and Data Processing ......................................................................................................... 3 2 Table of 1130 Proteins Measured .......................................................................................................... 4 3 Variable Selection and Statistical Modeling ........................................................................................
    [Show full text]
  • Artemin-Stimulated Progression of Human Non–Small Cell Lung Carcinoma Is Mediated by BCL2
    Published OnlineFirst June 8, 2010; DOI: 10.1158/1535-7163.MCT-09-1077 Research Article Molecular Cancer Therapeutics Artemin-Stimulated Progression of Human Non–Small Cell Lung Carcinoma Is Mediated by BCL2 Jian-Zhong Tang1, Xiang-Jun Kong3, Jian Kang1, Graeme C. Fielder1, Michael Steiner1, Jo K. Perry1, Zheng-Sheng Wu4, Zhinan Yin5, Tao Zhu3, Dong-Xu Liu1, and Peter E. Lobie1,2 Abstract We herein show that Artemin (ARTN), one of the glial cell line–derived neurotrophic factor family of li- gands, promotes progression of human non–small cell lung carcinoma (NSCLC). Oncomine data indicate that expression of components of the ARTN signaling pathway (ARTN, GFRA3, and RET) is increased in neoplas- tic compared with normal lung tissues; increased expression of ARTN in NSCLC also predicted metastasis to lymph nodes and a higher grade in certain NSCLC subtypes. Forced expression of ARTN stimulated survival, anchorage-independent, and three-dimensional Matrigel growth of NSCLC cell lines. ARTN increased BCL2 expression by transcriptional upregulation, and inhibition of BCL2 abrogated the oncogenic properties of ARTN in NSCLC cells. Forced expression of ARTN also enhanced migration and invasion of NSCLC cells. Forced expression of ARTN in H1299 cells additionally resulted in larger xenograft tumors, which were high- ly proliferative, invasive, and metastatic. Concordantly, either small interfering RNA–mediated depletion or functional inhibition of endogenous ARTN with antibodies reduced oncogenicity and invasiveness of NSCLC cells. ARTN therefore mediates progression of NSCLC and may be a potential therapeutic target for NSCLC. Mol Cancer Ther; 9(6); 1697–708. ©2010 AACR. Introduction Therefore, identification and subsequent targeting of novel oncogenic pathways may provide an advantage to Lung carcinoma is currently responsible for the highest the current regimens used to treat lung carcinoma and cancer-related mortality worldwide, with overall 5-year consequently improve prognosis.
    [Show full text]
  • A Bioinformatics Model of Human Diseases on the Basis Of
    SUPPLEMENTARY MATERIALS A Bioinformatics Model of Human Diseases on the basis of Differentially Expressed Genes (of Domestic versus Wild Animals) That Are Orthologs of Human Genes Associated with Reproductive-Potential Changes Vasiliev1,2 G, Chadaeva2 I, Rasskazov2 D, Ponomarenko2 P, Sharypova2 E, Drachkova2 I, Bogomolov2 A, Savinkova2 L, Ponomarenko2,* M, Kolchanov2 N, Osadchuk2 A, Oshchepkov2 D, Osadchuk2 L 1 Novosibirsk State University, Novosibirsk 630090, Russia; 2 Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences, Novosibirsk 630090, Russia; * Correspondence: [email protected]. Tel.: +7 (383) 363-4963 ext. 1311 (M.P.) Supplementary data on effects of the human gene underexpression or overexpression under this study on the reproductive potential Table S1. Effects of underexpression or overexpression of the human genes under this study on the reproductive potential according to our estimates [1-5]. ↓ ↑ Human Deficit ( ) Excess ( ) # Gene NSNP Effect on reproductive potential [Reference] ♂♀ NSNP Effect on reproductive potential [Reference] ♂♀ 1 increased risks of preeclampsia as one of the most challenging 1 ACKR1 ← increased risk of atherosclerosis and other coronary artery disease [9] ← [3] problems of modern obstetrics [8] 1 within a model of human diseases using Adcyap1-knockout mice, 3 in a model of human health using transgenic mice overexpressing 2 ADCYAP1 ← → [4] decreased fertility [10] [4] Adcyap1 within only pancreatic β-cells, ameliorated diabetes [11] 2 within a model of human diseases
    [Show full text]
  • Growth Factors Acting Via Endothelial Cell-Specific Receptor Tyrosine Kinases: Vegfs, Angiopoietins, and Ephrins in Vascular Development
    Downloaded from genesdev.cshlp.org on September 25, 2021 - Published by Cold Spring Harbor Laboratory Press REVIEW Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, Angiopoietins, and ephrins in vascular development Nicholas W. Gale1 and George D. Yancopoulos Regeneron Pharmaceuticals, Inc., Tarrytown, New York 10591-6707 USA The term ‘vasculogenesis’ refers to the earliest stages of since been shown to be a critical regulator of endothelial vascular development, during which vascular endotheli- cell development. Not surprisingly, the specificity of al cell precursors undergo differentiation, expansion, and VEGF-A for the vascular endothelium results from the coalescence to form a network of primitive tubules restricted distribution of VEGF-A receptors to these (Risau 1997). This initial lattice, consisting purely of en- cells. The need to regulate the multitude of cellular in- dothelial cells that have formed rather homogenously teractions involved during vascular development sug- sized interconnected vessels, has been referred to as the gested that VEGF-A might not be alone as an endothelial primary capillary plexus. The primary plexus is then re- cell-specific growth factor. Indeed, there has been a re- modeled by a process referred to as angiogenesis (Risau cent explosion in the number of growth factors that spe- 1997), which involves the sprouting, branching, and dif- cifically act on the vascular endothelium. This explosion ferential growth of blood vessels to form the more ma- involves the VEGF family, which now totals at least five ture appearing vascular patterns seen in the adult organ- members. In addition, an entirely unrelated family of ism. This latter phase of vascular development also in- growth factors, known as the Angiopoietins, recently has volves the sprouting and penetration of vessels into been identified as acting via endothelial cell-specific re- previously avascular regions of the embryo, and also the ceptors known as the Ties.
    [Show full text]